RVL Pharmaceuticals plc
RVLPQ
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.16M | 32.64M | 44.54M | 59.75M | 27.41M |
| Total Receivables | 1.93M | 1.88M | 3.03M | 3.28M | 1.83M |
| Inventory | 1.36M | 213.00K | 784.00K | 621.00K | 528.00K |
| Prepaid Expenses | 3.31M | 3.62M | 8.62M | 7.26M | 9.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 1.13M |
| Total Current Assets | 25.75M | 38.35M | 56.98M | 70.91M | 40.19M |
|
|
|||||
| Total Current Assets | 25.75M | 38.35M | 56.98M | 70.91M | 40.19M |
| Net Property, Plant & Equipment | 3.81M | 3.01M | 1.79M | 1.38M | 1.58M |
| Long-term Investments | 55.85M | 55.85M | 55.85M | 55.85M | 55.85M |
| Goodwill | 55.85M | 55.85M | 55.85M | 55.85M | 55.85M |
| Total Other Intangibles | -- | 13.90M | 13.90M | 27.21M | 27.21M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 85.40M | 111.11M | 128.51M | 155.36M | 124.83M |
|
|
|||||
| Total Accounts Payable | 2.53M | 2.63M | 2.41M | 7.00M | 5.44M |
| Total Accrued Expenses | 6.81M | 7.46M | 13.47M | 12.71M | 11.02M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 57.96M | 4.47M | 1.88M | 520.00K | 1.16M |
| Total Finance Division Other Current Liabilities | 1.10M | 1.86M | 1.97M | 1.25M | 942.00K |
| Total Other Current Liabilities | 1.10M | 1.86M | 1.97M | 1.25M | 942.00K |
| Total Current Liabilities | 68.39M | 16.41M | 19.72M | 21.48M | 18.56M |
|
|
|||||
| Total Current Liabilities | 68.39M | 16.41M | 19.72M | 21.48M | 18.56M |
| Long-Term Debt | -- | 53.04M | 55.50M | 55.90M | 42.90M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 192.00K | 244.00K | 112.00K | 240.00K | 349.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 494.00K | 1.42M | 2.08M | 9.19M | 4.52M |
| Total Liabilities | 69.08M | 71.11M | 77.42M | 86.81M | 66.32M |
|
|
|||||
| Common Stock & APIC | 621.05M | 620.83M | 620.32M | 619.45M | 594.97M |
| Retained Earnings | -604.72M | -580.83M | -569.22M | -550.90M | -536.46M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 16.33M | 40.00M | 51.09M | 68.55M | 58.51M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 16.33M | 40.00M | 51.09M | 68.55M | 58.51M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 16.33M | 40.00M | 51.09M | 68.55M | 58.51M |
|
|
|||||